CONVERTIBLE BRIDGE LOAN AGREEMENTConvertible Bridge Loan Agreement • March 5th, 2018 • Kitov Pharma Ltd. • Pharmaceutical preparations
Contract Type FiledMarch 5th, 2018 Company IndustryThis Convertible Bridge Loan Agreement (the “Agreement”) is made and entered into as of September 15, 2017 (the “Effective Date”), by and between Tyrnovo Ltd., an Israeli Private Company, Number 51-496405-5 (the “Company”) and Kitov Pharmaceuticals Holdings Ltd., an Israeli public traded company, Number 52-003123-8 (the “Lender”). each of the Lender and the Company shall be referred as a “Party”, and collectively the “Parties”.
REVOLVING SECURED FACILITY AND PLEDGE AGREEMENTRevolving Secured Facility and Pledge Agreement • March 5th, 2018 • Kitov Pharma Ltd. • Pharmaceutical preparations
Contract Type FiledMarch 5th, 2018 Company IndustryThis Revolving Secured Facility and Pledge Agreement (this “Agreement”) is made and entered into on March 1, 2017 (the “Effective Date”), by and between TyrNovo Ltd., an Israeli company of Tel Aviv, Israel (the “Borrower”), and the entities listed in Appendix A (each a “Lender” and together the “Lenders”).
STOCK PURCHASE AGREEMENT by and among KITOV PHARMACEUTICALS HOLDINGS LTD. as the Buyer and CERTAIN STOCKHOLDERS OF TYRNOVO LTD. as the Sellers and MR. RAANAN BAR-ZOHAR as the Stockholders Representative Dated as of October 3, 2017 STOCK PURCHASE AGREEMENTStock Purchase Agreement • March 5th, 2018 • Kitov Pharma Ltd. • Pharmaceutical preparations
Contract Type FiledMarch 5th, 2018 Company IndustryThis Stock Purchase Agreement (this “Agreement”) is entered into as of October 3, 2017, by and among Kitov Pharmaceuticals Holdings Ltd., an Israeli publicly traded corporation (“Buyer”), certain stockholders of TyrNovo Ltd., an Israeli private corporation (the “Company”), who are identified on Exhibit A attached hereto (collectively “Sellers” and individually a “Seller”), and Mr. Raanan Bar-Zohar, Adv. of Balter, Guth, Aloni & Co. Law Offices (the “Stockholder Representative”). Buyer, each of the Sellers and the Stockholder Representative are sometimes referred to individually herein as a “Party” and collectively as the “Parties.”